Agenus Inc. (Nasdaq: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, today announced that the company will be presenting at the 16th Annual BIO CEO & Investor Conference on Monday, February 10th at 9:30 am EST in the Conrad Room. Hosted by the Biotechnology Industry Organization (BIO), the 16th Annual BIO CEO & Investor Conference will take place February 10-11 at the Waldorf Astoria in New York City.
Help employers find you! Check out all the jobs and post your resume.
